viridiol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5459246 |
| SCHEMBL ID | 2258148 |
| MeSH ID | M0156476 |
| Synonym |
|---|
| nsc-658706 |
| NSC658706 , |
| viridiol |
| 23820-80-6 |
| 1f736q9a8d , |
| unii-1f736q9a8d |
| cyclopenta(7,8)phenanthro(10,1-bc)furan-6,9-dione, 1,2,3,7,8,11b-hexahydro-1,3-dihydroxy-2-methoxy-, (1s-(1alpha,2alpha,3alpha,11balpha))- |
| nsc 658706 |
| SCHEMBL2258148 |
| HB4121 |
| HB3700 |
| 18-norandrosta-5,8,11,13-tetraeno(6,5,4-bc)furan-7,17-dione, 1,3-dihydroxy-2-methoxy-, (1.beta.,2.beta.,3.beta.)- |
| J-015227 |
| (1r,16r,17s,18s)-16,18-dihydroxy-17-methoxy-1-methyl-13-oxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),3,5(9),12(19),14-pentaene-6,11-dione |
| Q27252349 |
| HY-124551 |
| CS-0086900 |
| 3-betaalcohol-viridin |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.08) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||